Previous close | 10,878.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 2,909,494 |
Market cap | 168.386B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 35.50 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (2.10%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.
Astrazeneca (AZN) closed the most recent trading day at $69.45, moving +1.97% from the previous trading session.